Replacement of invasive diagnostic coronary procedures by innovative noninvasive Imaging Technologies
- Conditions
- AtherosclerosisCoronary artery disease10011082
- Registration Number
- NL-OMON47060
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 440
- Planned for a ICA as part of standard clinical care for evaluation of suspected CAD
- Age >=18 years
- Unable to provide written informed consent
- ICA planned for other reasons than suspected obstructive CAD (e.g. screening prior to lung transplantation, valvular surgery, or ICD implantation)
- Significant arrhythmia deemed to interfer with successful ECG triggered non-invasive imaging as judged by a cardiologist.
- Renal insufficiency: GFR <50ml/min
- Known anaphylactic allergy to iodine
- Known severe comorbidities with a life expectancy of less than 1 year
- Known severe claustrophobia
- Known contra-indications for beta-blocker or adenosine
- Instable coronary artery disease (acute coronary syndrome or instable angina)
- Other contraindications for CTA or MR perfusion (e.g. presence of incompatible pacemaker or ICD devices/leads, pregnancy, BMI >35 kg/m2).
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method